BF.B
43
-7
LB
38
-7
TDC
59
10
CMG
51
-3
STZ
63
10
PG
51
3
TXT
58
-2
PFE
30
-3
CME
42
-4
WAT
54
2
TGNA
48
-2
MCO
80
2
PCG
80
3
CHD
54
6
EBAY
47
-2
WBA
24
-3
ITW
62
-2
A
44
-2
EQR
54
-2
EXPD
53
-3
BF.B
43
-7
LB
38
-7
TDC
59
10
CMG
51
-3
STZ
63
10
PG
51
3
TXT
58
-2
PFE
30
-3
CME
42
-4
WAT
54
2
TGNA
48
-2
MCO
80
2
PCG
80
3
CHD
54
6
EBAY
47
-2
WBA
24
-3
ITW
62
-2
A
44
-2
EQR
54
-2
EXPD
53
-3
Financhill
Back

Frontier Communications Parent Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
48

FYBR
Frontier Communications Parent

Last Price:
35.63
Seasonality Move:
21.97%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
48
Frontier Communications Parent (FYBR) is a Sell

Is Frontier Communications Parent a Buy, Sell or Hold?

  • The current Frontier Communications Parent [FYBR] share price is $35.65. The Score for FYBR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • FYBR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FYBR Stock Price Chart

What is Frontier Communications Parent's stock price today?

  • The Frontier Communications Parent share price today is $35.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FYBR is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

FYBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.9 Buy
Relative Strength Index (14 RSI): 62.99 Buy
Chaikin Money Flow: 1143099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.74 - 36.1) Buy
Bollinger Bands (100): (24.55 - 31.27) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

FYBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.76 Sell
20-day SMA: 33.38 Buy
50-day SMA: 30.07 Buy
200-day SMA: 25.76 Buy
8-day EMA: 35.4 Buy
20-day EMA: 33.75 Buy
50-day EMA: 30.92 Buy
200-day EMA: 26.22 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Frontier Communications Parent Earnings Growth & FYBR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.67 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Frontier Communications Parent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):